TR199903096T2 - Diabetin tiazolidinedion ve s�lfonil�re ile tedavisi. - Google Patents
Diabetin tiazolidinedion ve s�lfonil�re ile tedavisi.Info
- Publication number
- TR199903096T2 TR199903096T2 TR1999/03096T TR9903096T TR199903096T2 TR 199903096 T2 TR199903096 T2 TR 199903096T2 TR 1999/03096 T TR1999/03096 T TR 1999/03096T TR 9903096 T TR9903096 T TR 9903096T TR 199903096 T2 TR199903096 T2 TR 199903096T2
- Authority
- TR
- Turkey
- Prior art keywords
- treatment
- diabetes
- thiazolidinedione
- sulfonylureas
- diabetes mellitus
- Prior art date
Links
- 206010012601 diabetes mellitus Diseases 0.000 title abstract 4
- ZOBPZXTWZATXDG-UHFFFAOYSA-N 1,3-thiazolidine-2,4-dione Chemical compound O=C1CSC(=O)N1 ZOBPZXTWZATXDG-UHFFFAOYSA-N 0.000 title 1
- 229940100389 Sulfonylurea Drugs 0.000 title 1
- 229940123464 Thiazolidinedione Drugs 0.000 title 1
- 241000124008 Mammalia Species 0.000 abstract 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract 2
- 102000004877 Insulin Human genes 0.000 abstract 1
- 108090001061 Insulin Proteins 0.000 abstract 1
- 229940122199 Insulin secretagogue Drugs 0.000 abstract 1
- 229940125396 insulin Drugs 0.000 abstract 1
- 230000003914 insulin secretion Effects 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9712854.0A GB9712854D0 (en) | 1997-06-18 | 1997-06-18 | Novel method of treatment |
| GBGB9806710.1A GB9806710D0 (en) | 1998-03-27 | 1998-03-27 | Novel method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR199903096T2 true TR199903096T2 (xx) | 2000-08-21 |
Family
ID=26311744
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR1999/03096T TR199903096T2 (xx) | 1997-06-18 | 1998-06-15 | Diabetin tiazolidinedion ve s�lfonil�re ile tedavisi. |
Country Status (33)
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9715295D0 (en) * | 1997-07-18 | 1997-09-24 | Smithkline Beecham Plc | Novel method of treatment |
| US7045519B2 (en) | 1998-06-19 | 2006-05-16 | Chiron Corporation | Inhibitors of glycogen synthase kinase 3 |
| PT1284268E (pt) | 1999-04-23 | 2008-03-10 | Smithkline Beecham Plc | Preparação de uma forma polimórfica de um derivado de tiazolidinodiona |
| AU1452601A (en) | 1999-11-01 | 2001-05-14 | Wisconsin Alumni Research Foundation | Cholesterol transport gene |
| ATE508738T1 (de) | 2001-01-12 | 2011-05-15 | Sun Pharma Advanced Res Co Ltd | System zur beabstandeten abgabe von arzneimitteln |
| KR100698595B1 (ko) * | 2003-09-29 | 2007-03-21 | 보령제약 주식회사 | 무정형 또는 준결정형 글리메피리드, 이의 제조방법 및 무정형 또는 준결정형 글리메피리드를 포함하는 약학적조성물 |
| PL1677792T3 (pl) | 2003-10-31 | 2016-05-31 | Takeda Pharmaceuticals Co | Stały preparat zawierający pioglitazon, glimepiryd i ester polioksyetylenosorbitanu z kwasem tłuszczowym |
| KR20080080126A (ko) | 2005-12-22 | 2008-09-02 | 다케다 야쿠힌 고교 가부시키가이샤 | 인슐린 감작제를 함유하는 고체 제제 |
| CN104158867B (zh) * | 2014-08-06 | 2017-05-17 | 电子科技大学 | 一种基于wave协议的信息多跳转发方法 |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5522636A (en) | 1978-08-04 | 1980-02-18 | Takeda Chem Ind Ltd | Thiazoliding derivative |
| JPS5697277A (en) | 1980-01-07 | 1981-08-05 | Takeda Chem Ind Ltd | Thiazolidine derivative |
| JPS6051189A (ja) | 1983-08-30 | 1985-03-22 | Sankyo Co Ltd | チアゾリジン誘導体およびその製造法 |
| US4582839A (en) | 1984-03-21 | 1986-04-15 | Takeda Chemical Industries, Ltd. | 2,4-thiazolidinediones |
| CN1003445B (zh) | 1984-10-03 | 1989-03-01 | 武田药品工业株式会社 | 噻唑烷二酮衍生物，其制备方法和用途 |
| DK173350B1 (da) | 1985-02-26 | 2000-08-07 | Sankyo Co | Thiazolidinderivater, deres fremstilling og farmaceutisk paæparat indeholdende dem |
| JPH06779B2 (ja) | 1985-06-10 | 1994-01-05 | 武田薬品工業株式会社 | チアゾリジオン誘導体およびそれを含んでなる医薬組成物 |
| US4812570A (en) | 1986-07-24 | 1989-03-14 | Takeda Chemical Industries, Ltd. | Method for producing thiazolidinedione derivatives |
| EP0306228B1 (en) * | 1987-09-04 | 1999-11-17 | Beecham Group Plc | Substituted thiazolidinedione derivatives |
| US4791125A (en) | 1987-12-02 | 1988-12-13 | Pfizer Inc. | Thiazolidinediones as hypoglycemic and anti-atherosclerosis agents |
| WO1989008651A1 (en) | 1988-03-08 | 1989-09-21 | Pfizer Inc. | Hypoglycemic thiazolidinedione derivatives |
| FI904414A7 (fi) | 1988-03-08 | 1990-09-07 | Pfizer | Tiatsolidiinidioni-hypoglykeemisesti vaikuttavat aineet |
| WO1991007107A1 (en) | 1989-11-13 | 1991-05-30 | Pfizer Inc. | Oxazolidinedione hypoglycemic agents |
| US5089514A (en) | 1990-06-14 | 1992-02-18 | Pfizer Inc. | 3-coxazolyl [phenyl, chromanyl or benzofuranyl]-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents |
| HUT65619A (en) | 1990-07-03 | 1994-07-28 | Yamanouchi Pharma Co Ltd | Process for producing bisheterocyclic compounds and pharmaceutical preparations containing them |
| DK0544696T3 (da) | 1990-08-23 | 1995-06-06 | Pfizer | Hypoglycæmiske hydroxyurinstofderivater |
| JPH04210683A (ja) | 1990-12-06 | 1992-07-31 | Terumo Corp | チアゾリジン−２，４−ジオン誘導体およびこれを含有する糖尿病合併症治療薬 |
| AU1743292A (en) | 1991-04-11 | 1992-11-17 | Takeda Chemical Industries Ltd. | Thiazolidinedione derivatives, production and use thereof |
| US5183823A (en) | 1991-04-11 | 1993-02-02 | Takeda Chemical Industries, Ltd. | Pyridine n-oxide compounds which are useful as hypoglycemic and hypolipidemic agents |
| TW222626B (forum.php) | 1991-07-22 | 1994-04-21 | Pfizer | |
| FR2680512B1 (fr) | 1991-08-20 | 1995-01-20 | Adir | Nouveaux derives de 2,4-thiazolidinedione, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| ATE151634T1 (de) * | 1991-08-26 | 1997-05-15 | Upjohn Co | Flüssiges nahrungsmittel, das 3- guanidinopropionsäure enthält |
| JPH05271204A (ja) | 1992-03-26 | 1993-10-19 | Japan Tobacco Inc | 新規なトリアジン誘導体 |
| US5264451A (en) | 1992-04-07 | 1993-11-23 | American Home Products Corporation | Process for treating hyperglycemia using trifluoromethyl substituted 3H-pyrazol-3-ones |
| EP0635007A1 (en) | 1992-04-10 | 1995-01-25 | Smithkline Beecham Plc | Heterocyclic compounds and their use in the treatment of type ii-diabetes |
| AU4104593A (en) | 1992-05-05 | 1993-11-29 | Upjohn Company, The | A process for producing pioglitazone metabolite |
| RU2134686C1 (ru) | 1992-07-03 | 1999-08-20 | Смитклайн Бичам П.Л.С. | Гетероциклическое соединение, или его таутомерная форма, и/или фармацевтически приемлемая соль, и/или фармацевтически приемлемый сольват, фармацевтическая композиция, снижающая содержание глюкозы в крови, способ лечения и/или профилактики гипергликемии |
| US5232945A (en) | 1992-07-20 | 1993-08-03 | Pfizer Inc. | 3-aryl-2-hydroxypropionic acid derivatives and analogs as antihypertensives |
| GB9218830D0 (en) | 1992-09-05 | 1992-10-21 | Smithkline Beecham Plc | Novel compounds |
| US5457109A (en) | 1993-09-15 | 1995-10-10 | Warner-Lambert Company | Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus |
| TW438587B (en) * | 1995-06-20 | 2001-06-07 | Takeda Chemical Industries Ltd | A pharmaceutical composition for prophylaxis and treatment of diabetes |
| US5859037A (en) * | 1997-02-19 | 1999-01-12 | Warner-Lambert Company | Sulfonylurea-glitazone combinations for diabetes |
-
1998
- 1998-06-15 CZ CZ0457799A patent/CZ299310B6/cs not_active IP Right Cessation
- 1998-06-15 WO PCT/EP1998/003688 patent/WO1998057649A1/en active IP Right Grant
- 1998-06-15 IL IL13313798A patent/IL133137A/en not_active IP Right Cessation
- 1998-06-15 AU AU85392/98A patent/AU8539298A/en not_active Abandoned
- 1998-06-15 ID IDW991628A patent/ID24065A/id unknown
- 1998-06-15 KR KR1020087001560A patent/KR20080011356A/ko not_active Ceased
- 1998-06-15 AT AT98936363T patent/ATE353654T1/de not_active IP Right Cessation
- 1998-06-15 KR KR1020077000227A patent/KR20070011651A/ko not_active Ceased
- 1998-06-15 NZ NZ501163A patent/NZ501163A/en unknown
- 1998-06-15 BR BR9810142-0A patent/BR9810142A/pt not_active Application Discontinuation
- 1998-06-15 EP EP98936363A patent/EP0999845B1/en not_active Expired - Lifetime
- 1998-06-15 EP EP06075523A patent/EP1671637A3/en not_active Ceased
- 1998-06-15 PL PL377979A patent/PL198018B1/pl not_active IP Right Cessation
- 1998-06-15 EA EA200000039A patent/EA003025B1/ru not_active IP Right Cessation
- 1998-06-15 KR KR1019997011861A patent/KR20010013840A/ko not_active Ceased
- 1998-06-15 CN CNB988061880A patent/CN1168451C/zh not_active Expired - Fee Related
- 1998-06-15 JP JP50375499A patent/JP2001523270A/ja active Pending
- 1998-06-15 ES ES98936363T patent/ES2283064T3/es not_active Expired - Lifetime
- 1998-06-15 UA UA99126878A patent/UA67743C2/uk unknown
- 1998-06-15 SK SK1791-99A patent/SK286028B6/sk not_active IP Right Cessation
- 1998-06-15 PL PL98337510A patent/PL337510A1/xx not_active Application Discontinuation
- 1998-06-15 EP EP10176770A patent/EP2266576A1/en not_active Withdrawn
- 1998-06-15 TR TR1999/03096T patent/TR199903096T2/xx unknown
- 1998-06-15 DE DE69837089T patent/DE69837089T2/de not_active Expired - Lifetime
- 1998-06-15 AP APAP/P/1999/001717A patent/AP1600A/en active
- 1998-06-15 CA CA002294385A patent/CA2294385C/en not_active Expired - Fee Related
- 1998-06-17 DZ DZ980132A patent/DZ2522A1/xx active
- 1998-06-17 MA MA25120A patent/MA24571A1/fr unknown
- 1998-06-17 AR ARP980102881A patent/AR012996A1/es unknown
- 1998-06-17 TW TW087109616A patent/TW542717B/zh not_active IP Right Cessation
- 1998-06-17 MY MYPI98002709A patent/MY125855A/en unknown
- 1998-06-17 AR ARP980102879A patent/AR008025A1/es not_active Application Discontinuation
- 1998-06-18 CO CO98034645A patent/CO4940457A1/es unknown
- 1998-06-18 UY UY25048A patent/UY25048A1/es not_active Application Discontinuation
- 1998-06-18 IN IN1692DE1998 patent/IN189319B/en unknown
- 1998-06-18 PE PE1998000532A patent/PE108199A1/es not_active Application Discontinuation
-
1999
- 1999-12-17 NO NO19996264A patent/NO326263B1/no not_active IP Right Cessation
- 1999-12-17 OA OA9900293A patent/OA11510A/en unknown
-
2000
- 2000-01-06 BG BG104058A patent/BG64817B1/bg unknown
- 2000-01-06 BG BG109397A patent/BG109397A/bg unknown
-
2008
- 2008-07-24 NO NO20083276A patent/NO20083276L/no not_active Application Discontinuation
-
2009
- 2009-02-13 NO NO2009002C patent/NO2009002I1/no unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BG104060A (en) | Diabetes treatment with thiazolyidindion and methformine | |
| NO940436D0 (no) | Forlenget avgivelse av peptider | |
| TR200000134T2 (tr) | Tiazolidinedion, ensülin salgılatıcısı ve biguanid ile diabetin (şeker hastalığının) tedavisi. | |
| TR200100079T2 (tr) | Glikoza karşı ß-hücre tepkisini arttıran glukagon benzeri peptid-1 | |
| NO994520D0 (no) | Sinkfrie insulinkrystaller for anvendelse i pulmonale preparater | |
| FI902193A7 (fi) | Polttoainekennopaketti, joka on varustettu sisäänrakennetulla kokoomaputkistolla | |
| TR199903096T2 (xx) | Diabetin tiazolidinedion ve s�lfonil�re ile tedavisi. | |
| DE59508174D1 (de) | Künstlicher zahn | |
| ATE81200T1 (de) | Biegsamer mehrschichtschutzschild. | |
| IL89481A0 (en) | Thiazolidinedione derivatives as hypoglycemic agents | |
| DE50102300D1 (de) | Hochgefülltes Kunststoffteil | |
| EA200000042A1 (ru) | Способ лечения диабета росиглитазоном и инсулином | |
| SE8700137D0 (sv) | Diuretisk komposition | |
| TR200000135T2 (tr) | Tiazolidinedion ve sülfonilüre ile diabet tedavisi. | |
| TR199903072T2 (xx) | Diabetin tiazolidinedion ve alfa-glukosidaz ile tedavisi. | |
| AP2000001735A0 (en) | Treatment of diabetes with thiazolidinedione insulin secretagogue and alpha glucocidase inhibitor. | |
| TR200101336T2 (tr) | Bir-beta-agonisti ile başka bir antidiyabetik madde içeren kombinasyonlar | |
| IT1229406B (it) | Macchina per l'apritura e la miscelazione di cotone in fiocco, a struttura perfezionata. | |
| WO2003003971A3 (fr) | Utilisation d'agents antidiabetiques pour fabriquer un medicament ayant un effet cicatrisant | |
| IL143088A0 (en) | A method for the treatment of type 2 diabetes mellitus and conditions associated therewith, and a pharmaceutical composition comprising an insulin sensitiser for use in such a method | |
| RU1775517C (ru) | Устройство дл контрол перекоса утка в ткан х | |
| ECSP982534A (es) | Nuevo metodo de tratamiento | |
| IT8919496A0 (it) | Dispositivo di tenuta fra un albero e una struttura fissa rispetto all'albero. |